Aging reversal enters human trials
His recurring headline: Life Biosciences' ER-100 got FDA clearance, dosed humans and reported interim results; Retro started Phase 1; clocks and biomarkers become the scoreboard.
Learning path
Start with the long-form interviews, then the science milestones he tracks, then the business and policy picture.
- Start here
Long-form interviews
- Step 2
Read his theses
- Step 3
Track the science
- Step 4
Go deeper by area
- Step 5
Business and geopolitics
Trends in 2026
Peptides and GLP-1s go mainstream
The single most frequent topic: grey-market peptides, the shift to federal policy, GLP-1 adoption at 12.4% of US adults, and retatrutide's Phase 3.
AI accelerates biology
Autonomous labs, AlphaFold successors, Claude Science, garage drug discovery and $200M+ AI-bio launches: "biology is moving at compute speed."
Fund the rails, not just the drugs
As an investor he keeps pointing at infrastructure: cheaper trials, manufacturing, data consortia, peptide validation.
Gene editing, embryo selection and fertility
Germline editing, IQ-screened embryos, artificial wombs, collapsing birth rates.
Geopolitics of biotech
China's trial speed and licensing boom, UAE money, US policy moves on peptides and psychedelics.
Human enhancement as culture
Enhanced Games, "Human 2.0", bio/acc as a movement; a lot of this is memes.
Resource library
People to follow
Mgoes@m_goes_distance · Author of this feed; Accelerate Bio hostGeorge Church@geochurch · Harvard geneticistAubrey de Grey@aubreydegrey · LEV FoundationDavid Sinclair@davidasinclair · Epigenetic reprogramming, Life BiosciencesJason Kelly@jrkelly · CEO Ginkgo BioworksMax Marchione@maxmarchione · CEO SuperpowerChristian Angermayer@C_Angermayer · Investor: psychedelics, Enhanced GamesCremieux@cremieuxrecueil · Trial results and embryo selection commentaryBryan Johnson@bryan_johnson · Don't Die, BlueprintMartin Varsavsky@martinvars · IVF clinics founderKevin Weil@kevinweil · Warp SciencesAdam Draper@AdamDraper · Boost VC, "body is a software problem"
Companies to watch
Life BiosciencesER-100 epigenetic reprogramming trialRetro BiosciencesRTR242, AI drug discoveryNewLimitEpigenetic reprogramming, $130MAltos LabsBezos-backed rejuvenationGinkgo BioworksAutonomous labsIsomorphic LabsAI drug design, $2.1BWarp SciencesAI + robotics for medicinesEli LillyTirzepatide, retatrutideSuperpowerConsumer diagnosticsHerasightEmbryo selectionNucleusEmbryo screeningEnhanced GamesSupervised enhancement sportDognosisCancer detection with dogs + BCILume HealthProtocol trackingChai DiscoveryAI biologicsAleph SurgeryRobot surgeon